Listed with other top experts in: 

2003 to

(Undisclosed)

President

Expert is responsible for all areas of operation for a consulting and information services business: attracting and developing relationships with various potential clients; developing a business plan for operations of the company; and has provided reports and data for clients on various topics related to science, marketing, and competitive intelligence.

1998 to 2003

Cell Therapeutics, Inc.

Senior Staff Chemist

He was responsible for planning the development work for poly-glutamate polymer-paclitaxel conjugate (CT-2103) for four years. He participated and presented information for several due diligence potential partnerships. He was responsible for manufacturing campaigns under current Good Manufacturing Practice at various vendor sites, and for initial vendor audit and selection. He has extensive knowledge of the chemistry of paclitaxel. Expert was responsible for chemistry manufacturing and controls CT-2103 cross-functional group (analytical development, process development, formulation development, quality control, quality assurance, document control, active pharmaceutical ingredient manufacturing, finished product manufacturing). He was a core team member for CT-2103 (poly-glutamic acid paclitaxel polymer conjugate) on cross-functional team (regulatory, marketing, research, preclinical/toxicology, project management, clinical) representing manufacturing, and quality control. He was responsible for three years for multimillion-dollar budgets directly related to manufacturing and development; indirectly responsible for tens of millions of budget dollars and came within 3% of the budget, usually under budget.

1997 to 1998

Synthetech

Senior Process Development Chemist

Expert designed and refined synthetic schemes for the synthesis of specialty amino acids and peptide building blocks. He optimized and improved existing synthetic sequences. He executed synthetic schemes and clarified results both at bench scale as well as pilot plant scale. He analyzed and interpreted information to decide the further course of projects. He did troubleshooting of operations in the pilot plant when problems occurred. He has pilot plant experience (22-liter flasks and 50 to 500-gallon reactors).

1992 to 1997

Bristol-Myers Squibb

Research Scientist

He designed and refined synthetic schemes for the synthesis of key targets. He optimized and improved existing synthetic sequences for utilization in a kilo-lab. He executed synthetic schemes and clarified results. He analyzed and interpreted information to decide the further course of projects.